Showing 6 posts of 6 posts found.

Insys Therapeutics files for bankruptcy

June 11, 2019
Manufacturing and Production DoJ, Subsys, bankruptcy, insys, pharma

Opioid drugmaker Insys Therapeutics has filed for Chapter 11 bankruptcy protection after agreeing to pay $225 million to settle charges …


Insys Therapeutics founder John Kapoor found guilty of bribing doctors

May 3, 2019
Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma

The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …


Insys Therapeutics names current CFO Andrew Long as company’s new CEO

April 16, 2019
Manufacturing and Production CEO, Insys Therapeutics, Subsys, appointments, cfo, pharma

Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO. The opioid drugmaker …

Insys Therapeutics reaches $150m agreement to settle opioid marketing case

August 9, 2018
Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma

The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …


Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl

October 27, 2017
Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids

John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …


Insys Therapeutics sees revenue from Subsys at $61-$62 million; shares plunge 21%

April 11, 2016
Business Services, Manufacturing and Production, Sales and Marketing Insys Therapeutics, Stock Price, Subsys, opioids, pain drug

Insys Therapeutics Inc (Nasdaq: INSY) stock plunged nearly 21% Monday after the company said sales for its pain drug will …

Latest content